{"DataElement":{"publicId":"2494496","version":"1","preferredName":"NSABP Patient Clinical Trial Eligibility Criteria B-42 Type","preferredDefinition":"the type of element of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by the NCI.","longName":"NSABP_PT_CTEC_B42_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2494489","version":"1","preferredName":"NSABP Patient Clinical Trial Eligibility Criteria","preferredDefinition":"information related to the elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by the NCI.","longName":"NSABP_PT_CTEC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2404995","version":"1","preferredName":"National Surgical Adjuvant Breast and Bowel Project Patient","preferredDefinition":"The National Surgical adjuvant Breast and Bowel Project (NSABP) is a clinical trials cooperative group supported by the NCI. The group headquarters in Pittsburgh, Pennsylvania and has research sites at nearly 200 major medical centers, university hospitals, large oncology practice groups, and health maintenance organizations in the United States, Canada, Puerto Rico, and Australia. . In addition to funding from the NCI, which the NSABP has received since it began, the NSABP also receives support from other sources for ancillary studies, training, and educational programs.:A person who requires medical care.","longName":"C15818:C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Surgical Adjuvant Breast and Bowel Project","conceptCode":"C15818","definition":"A clinical trials cooperative group supported by the NCI. The group headquarters in Pittsburgh, Pennsylvania and has research sites at nearly 200 major medical centers, university hospitals, large oncology practice groups, and health maintenance organizations in the United States, Canada, Puerto Rico, and Australia. In addition to funding from the NCI, which the NSABP has received since it began, the NSABP also receives support from other sources for ancillary studies, training, and educational programs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"00AD61C3-444D-1BBC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-14","modifiedBy":"ONEDATA","dateModified":"2005-09-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2494487","version":"1","preferredName":"Clinical Trial Eligibility Criteria","preferredDefinition":"Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"17D7DFE2-3794-35DA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ONEDATA","dateModified":"2006-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17D7DFE2-37A5-35DA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2494490","version":"1","preferredName":"B-42 Clinical Trial Eligibility Criteria Type","preferredDefinition":"the type of clinical trial eligibility criteria for NSABP B-42 protocol.","longName":"B42_CTEC_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Postmenopausal","valueDescription":"postmenopausal","ValueMeaning":{"publicId":"2563578","version":"1","preferredName":"postmenopausal","longName":"2563578","preferredDefinition":"Having to do with the time after menopause. Menopause (\"change of life\") is the time in a woman's life when menstrual periods stop permanently.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Postmenopausal","conceptCode":"C15421","definition":"After menopause.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C567-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-11-06","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-11-06","modifiedBy":"COOPERM","dateModified":"2018-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17D9456B-9C86-4112-E044-0003BA3F9857","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ALAIS","dateModified":"2006-07-05","deletedIndicator":"No"},{"value":"Disease-free from initial breast cancer diagnosis","valueDescription":"Disease-free from initial breast cancer diagnosis","ValueMeaning":{"publicId":"2580148","version":"1","preferredName":"Disease-free from initial breast cancer diagnosis","longName":"2580148","preferredDefinition":"Disease-free from initial breast cancer diagnosis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0621-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ALAIS","dateModified":"2006-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17D96D86-2344-4340-E044-0003BA3F9857","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ONEDATA","dateModified":"2006-07-05","deletedIndicator":"No"},{"value":"Primary tumor was pathologic or clinical Stage I, II or IIIA invasive breast carcinoma documented by core needle or open biopsy","valueDescription":"Primary tumor was pathologic or clinical Stage I, II or IIIA invasive breast carcinoma documented by core needle or open biopsy","ValueMeaning":{"publicId":"2580150","version":"1","preferredName":"Primary tumor was pathologic or clinical Stage I, II or IIIA invasive breast carcinoma documented by core needle or open biopsy","longName":"2580150","preferredDefinition":"Primary tumor was pathologic or clinical Stage I, II or IIIA invasive breast carcinoma documented by core needle or open biopsy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0623-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ALAIS","dateModified":"2006-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17D9891D-4145-6505-E044-0003BA3F9857","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ONEDATA","dateModified":"2006-07-05","deletedIndicator":"No"},{"value":"Primary tumor was ER-positive and/or PgR-positive","valueDescription":"Primary tumor was ER-positive and/or PgR-positive","ValueMeaning":{"publicId":"2580151","version":"1","preferredName":"Primary tumor was ER-positive and/or PgR-positive","longName":"2580151","preferredDefinition":"Primary tumor was ER-positive and/or PgR-positive","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0624-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ALAIS","dateModified":"2006-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17D9891D-4157-6505-E044-0003BA3F9857","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ONEDATA","dateModified":"2006-07-05","deletedIndicator":"No"},{"value":"No other malignancies within past 5 years","valueDescription":"No other malignancies within past 5 years","ValueMeaning":{"publicId":"2580152","version":"1","preferredName":"No other malignancies within past 5 years","longName":"2580152","preferredDefinition":"No other malignancies within past 5 years","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0625-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ALAIS","dateModified":"2006-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17D995C4-B325-5EEB-E044-0003BA3F9857","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ONEDATA","dateModified":"2006-07-05","deletedIndicator":"No"},{"value":"No history of non-traumatic osteoporotic bone fractures","valueDescription":"No history of non-traumatic osteoporotic bone fractures","ValueMeaning":{"publicId":"2580153","version":"1","preferredName":"No history of non-traumatic osteoporotic bone fractures","longName":"2580153","preferredDefinition":"No history of non-traumatic osteoporotic bone fractures","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0626-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ALAIS","dateModified":"2006-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17D99C91-DE03-65D5-E044-0003BA3F9857","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ONEDATA","dateModified":"2006-07-05","deletedIndicator":"No"},{"value":"No diagnosis of bilateral breast cancer including DCIS (synchronous or metachronous).","valueDescription":"No diagnosis of bilateral breast cancer including DCIS (synchronous or metachronous)","ValueMeaning":{"publicId":"2697723","version":"1","preferredName":"No diagnosis of bilateral breast cancer including DCIS (synchronous or metachronous)","longName":"2697723","preferredDefinition":"No diagnosis of bilateral breast cancer including DCIS (synchronous or metachronous)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F4DF967-00B1-266D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17D9A11C-08DD-63F0-E044-0003BA3F9857","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"CAMPBELB","dateModified":"2008-03-24","deletedIndicator":"No"},{"value":"Not currently on sex hormonal therapy","valueDescription":"Not currently on sex hormonal therapy","ValueMeaning":{"publicId":"2580155","version":"1","preferredName":"Not currently on sex hormonal therapy","longName":"2580155","preferredDefinition":"Not currently on sex hormonal therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0628-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ALAIS","dateModified":"2006-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17D995C4-B337-5EEB-E044-0003BA3F9857","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ONEDATA","dateModified":"2006-07-05","deletedIndicator":"No"},{"value":"All other protocol criteria met","valueDescription":"All other protocol criteria met","ValueMeaning":{"publicId":"2580157","version":"1","preferredName":"All other protocol criteria met","longName":"2580157","preferredDefinition":"All other protocol criteria met","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-062A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ALAIS","dateModified":"2006-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17D9AF3B-7E9A-62FE-E044-0003BA3F9857","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ONEDATA","dateModified":"2006-07-05","deletedIndicator":"No"},{"value":"Signed and Dated Consent","valueDescription":"Signed and Dated Consent","ValueMeaning":{"publicId":"2580158","version":"1","preferredName":"Signed and Dated Consent","longName":"2580158","preferredDefinition":"Signed and Dated Consent","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-062B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ALAIS","dateModified":"2006-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17D995C4-B349-5EEB-E044-0003BA3F9857","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ONEDATA","dateModified":"2006-07-05","deletedIndicator":"No"},{"value":"Lumpectomy + Axillary Staging + Radiation Therapy OR Total Mastectomy + Axillary Staging","valueDescription":"Lumpectomy + Axillary Staging + Radiation Therapy OR Total Mastectomy + Axillary Staging","ValueMeaning":{"publicId":"2580159","version":"1","preferredName":"Lumpectomy + Axillary Staging + Radiation Therapy OR Total Mastectomy + Axillary Staging","longName":"2580159","preferredDefinition":"Lumpectomy + Axillary Staging + Radiation Therapy OR Total Mastectomy + Axillary Staging","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-062C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ALAIS","dateModified":"2006-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17D9A11C-08EF-63F0-E044-0003BA3F9857","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ONEDATA","dateModified":"2006-07-05","deletedIndicator":"No"},{"value":"Currently taking an aromatase inhibitor or tamoxifen, and received a duration of 2 - 4.5 years (regardless of missed doses). Total tamoxifen duration must not exceed 3 years.","valueDescription":"Currently taking an aromatase inhibitor or tamoxifen with cumulative duration of 2 - 4.5 years and with tamoxifen duration of 0-3 years.","ValueMeaning":{"publicId":"2580160","version":"1","preferredName":"Currently taking an aromatase inhibitor or tamoxifen with cumulative duration of 2 - 4.5 years and with tamoxifen duration of 0-3 years.","longName":"2580160","preferredDefinition":"Currently taking an aromatase inhibitor or tamoxifen with cumulative duration of 2 - 4.5 years and with tamoxifen duration of 0-3 years.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-062D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ALAIS","dateModified":"2006-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17D9C74E-4BC0-662A-E044-0003BA3F9857","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"CAMPBELB","dateModified":"2008-03-24","deletedIndicator":"No"},{"value":"Not currently on any other investigational hormonal therapy or in any other hormonal therapy clinical trial","valueDescription":"Not currently on any other investigational hormonal therapy or in any other hormonal therapy clinical trial","ValueMeaning":{"publicId":"2580161","version":"1","preferredName":"Not currently on any other investigational hormonal therapy or in any other hormonal therapy clinical trial","longName":"2580161","preferredDefinition":"Not currently on any other investigational hormonal therapy or in any other hormonal therapy clinical trial","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-062E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ALAIS","dateModified":"2006-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17D9AF3B-7EAC-62FE-E044-0003BA3F9857","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ONEDATA","dateModified":"2006-07-05","deletedIndicator":"No"},{"value":"Not on any hormonal agent for osteoporosis","valueDescription":"Not on any hormonal agent for osteoporosis","ValueMeaning":{"publicId":"2580162","version":"1","preferredName":"Not on any hormonal agent for osteoporosis","longName":"2580162","preferredDefinition":"Not on any hormonal agent for osteoporosis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-062F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ALAIS","dateModified":"2006-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17DB5E9F-FF44-0091-E044-0003BA3F9857","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"ONEDATA","dateModified":"2006-07-05","deletedIndicator":"No"},{"value":"Histologically-confirmed invasive breast carcinoma by diagnostic core needle biopsy or final pathologic evaluation of surgical specimen","valueDescription":"Histologically-confirmed invasive breast carcinoma by diagnostic core needle biopsy or final pathologic evaluation of surgical specimen","ValueMeaning":{"publicId":"2697722","version":"1","preferredName":"Histologically-confirmed invasive breast carcinoma by diagnostic core needle biopsy or final pathologic evaluation of surgical specimen","longName":"2697722","preferredDefinition":"Histologically-confirmed invasive breast carcinoma by diagnostic core needle biopsy or final pathologic evaluation of surgical specimen","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F4DF3E6-5924-24D6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3F4DF47C-929B-24D8-E044-0003BA3F9857","beginDate":"2007-11-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-11-19","modifiedBy":"ONEDATA","dateModified":"2007-11-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17D94563-374C-404C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Eligibility Criteria","type":"Preferred Question Text","description":"Eligibility Criteria","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Protocol Eligibility","url":null,"context":"CTEP"}],"origin":"NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"17DB3B05-347E-0098-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-05","modifiedBy":"CAMPBELB","dateModified":"2011-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}